Drug Shortage Report for MS.IR

Last updated on 2021-12-10 History
Report ID 143048
Drug Identification Number 02014211
Brand name MS.IR
Common or Proper name Morphine Sulfate Sustained Release Tablets
Company Name PURDUE PHARMA
Market Status MARKETED
Active Ingredient(s) MORPHINE SULFATE
Strength(s) 10MG
Dosage form(s) TABLET (IMMEDIATE RELEASE)
Route of administration ORAL ORAL
Packaging size 60
ATC code N02AA
ATC description OPIOIDS
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date 2021-07-26
Actual start date 2021-07-26
Estimated end date 2021-12-17
Actual end date 2021-12-09
Shortage status Resolved
Updated date 2021-12-10
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 3381 STEELES AVENUE EAST
TORONTO, ONTARIO
CANADA M2H 3S7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2021-07-26 English Compare
v2 2021-07-26 French Compare
v3 2021-07-27 English Compare
v4 2021-08-04 English Compare
v5 2021-08-04 French Compare
v6 2021-09-10 English Compare
v7 2021-09-10 French Compare
v8 2021-10-14 English Compare
v9 2021-10-14 French Compare
v10 2021-11-03 English Compare
v11 2021-11-03 French Compare
v12 2021-11-11 English Compare
v13 2021-11-11 French Compare
v14 2021-11-18 English Compare
v15 2021-11-18 French Compare
v16 2021-11-26 English Compare
v17 2021-11-26 French Compare
v18 2021-12-02 English Compare
v19 2021-12-02 French Compare
v20 2021-12-08 English Compare

Showing 1 to 20 of 24